Ling Yu

1.4k total citations
44 papers, 1.1k citations indexed

About

Ling Yu is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Ling Yu has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Immunology and 12 papers in Genetics. Recurrent topics in Ling Yu's work include Virus-based gene therapy research (10 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). Ling Yu is often cited by papers focused on Virus-based gene therapy research (10 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). Ling Yu collaborates with scholars based in China, Japan and Hong Kong. Ling Yu's co-authors include Masatoshi Tagawa, Osamu Shimozato, Zhiqiang Yu, Kiyoko Kawamura, Meng Yu, Zhenjie Wang, Binhua Zou, Rui Sun, Yuanyuan Yang and Shijun Zhang and has published in prestigious journals such as ACS Nano, Gastroenterology and ACS Applied Materials & Interfaces.

In The Last Decade

Ling Yu

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Yu China 19 452 345 321 231 202 44 1.1k
Deepak B. Thimiri Govinda Raj Norway 18 651 1.4× 238 0.7× 401 1.2× 108 0.5× 139 0.7× 65 1.3k
Funan Liu China 20 613 1.4× 140 0.4× 302 0.9× 265 1.1× 187 0.9× 54 1.3k
Yuge Zhao China 22 524 1.2× 346 1.0× 153 0.5× 416 1.8× 110 0.5× 37 1.2k
Sufang Zhou China 20 690 1.5× 285 0.8× 240 0.7× 187 0.8× 48 0.2× 69 1.2k
Zhao Yang China 16 341 0.8× 148 0.4× 243 0.8× 145 0.6× 75 0.4× 35 907
Fang Xie China 21 489 1.1× 611 1.8× 451 1.4× 308 1.3× 64 0.3× 49 1.6k
Wen-Yu Pan Taiwan 21 509 1.1× 270 0.8× 200 0.6× 403 1.7× 52 0.3× 27 1.3k
Maura Montani Italy 24 712 1.6× 183 0.5× 340 1.1× 112 0.5× 144 0.7× 43 1.3k

Countries citing papers authored by Ling Yu

Since Specialization
Citations

This map shows the geographic impact of Ling Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Yu more than expected).

Fields of papers citing papers by Ling Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Yu. The network helps show where Ling Yu may publish in the future.

Co-authorship network of co-authors of Ling Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Yu. A scholar is included among the top collaborators of Ling Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Yu. Ling Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Jialin, Qi Pan, Guihao Chen, et al.. (2024). Triple Hybrid Cellular Nanovesicles Promote Cardiac Repair after Ischemic Reperfusion. ACS Nano. 18(5). 4443–4455. 30 indexed citations
2.
Huang, Bi‐Jun, Ling Yu, Hao Hu, et al.. (2022). Therapeutic Effect of Catgut Implantation at Acupoint in a Mouse Model of Hepatocellular Carcinoma by Suppressing Immune Escape. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 4 indexed citations
3.
Mo, Zhuomao, et al.. (2020). An Integrative Analysis Reveals the Potential Mechanism between Herbal Medicine Yinchen and Immunoregulation in Hepatocellular Carcinoma. BioMed Research International. 2020(1). 8886914–8886914. 8 indexed citations
4.
Hu, Hao, Liang Xu, Ting Xiang, et al.. (2020). Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma. International Journal of Medical Sciences. 17(13). 1897–1908. 10 indexed citations
5.
Bao, Li, Ying Zhou, Wen Yuan, et al.. (2020). Association between TERT gene polymorphisms and acute myeloid leukemia susceptibility in a Chinese population: a case–control study. Cancer Cell International. 20(1). 313–313. 8 indexed citations
6.
Hu, Hao, Zhuomao Mo, Yongdan Wang, et al.. (2020). Depressive Disorder promotes Hepatocellular Carcinoma metastasis via upregulation of ABCG2 gene expression and maintenance of self-renewal. Journal of Cancer. 11(18). 5309–5317. 8 indexed citations
7.
He, Ping, et al.. (2020). Oxygen self-enriched nanoplatform combined with US imaging and chemo/photothermal therapy for breast cancer. Nanomedicine Nanotechnology Biology and Medicine. 29. 102238–102238. 10 indexed citations
8.
Yang, Cuiling, Na Li, Yawen Wang, et al.. (2014). Serum Levels of B-Cell Activating Factor in Chronic Hepatitis B Virus Infection: Association with Clinical Diseases. Journal of Interferon & Cytokine Research. 34(10). 787–794. 20 indexed citations
9.
Zhang, Ping, Fang Li, Na Li, et al.. (2014). Genetic variations of SOCS1 are associated with chronic hepatitis B virus infection. Human Immunology. 75(8). 709–714. 7 indexed citations
10.
Tagawa, Masatoshi, Ling Yu, Takeshi Sato, et al.. (2014). Enhanced expression of the β4-galactosyltransferase 2 gene impairs mammalian tumor growth. Cancer Gene Therapy. 21(6). 219–227. 8 indexed citations
11.
Li, Xiuli, et al.. (2013). Antitumor activity of a polysaccharide fraction from Laminaria japonica on U14 cervical carcinoma-bearing mice. Tumor Biology. 35(1). 117–122. 26 indexed citations
12.
Shimozato, Osamu, Ling Yu, Akihiko Wada, et al.. (2012). Expression of a murine homolog of apoptosis-inducing human IL-24/MDA-7 in murine tumors fails to induce apoptosis or produce anti-tumor effects. Cellular Immunology. 275(1-2). 90–97. 3 indexed citations
13.
Zhai, Yun, Gangqiao Zhou, Guohong Deng, et al.. (2006). Estrogen Receptor α Polymorphisms Associated With Susceptibility to Hepatocellular Carcinoma in Hepatitis B Virus Carriers. Gastroenterology. 130(7). 2001–2009. 66 indexed citations
14.
Yu, Ling, Naohito Yamamoto, Kenji Kadomatsu, et al.. (2004). Midkine Promoter Can Mediate Transcriptional Activation of a Fused Suicide Gene in a Broader Range of Human Breast Cancer Compared with c-erbB-2 Promoter. Oncology. 66(2). 143–149. 11 indexed citations
15.
Yu, Ling, Katsuyuki Hamada, Masayoshi Namba, et al.. (2004). Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells. European Journal of Cancer. 40(11). 1787–1794. 22 indexed citations
16.
Ugai, Shin‐ichi, Osamu Shimozato, Ling Yu, et al.. (2003). Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects. Cancer Gene Therapy. 10(10). 771–778. 61 indexed citations
17.
Yu, Ling, Katsuyuki Hamada, Masayoshi Namba, et al.. (2003). Insertion of an exogenous promoter in the E1A regulatory region of adenovirus does not disturb viral replication despite reduced E1A transcription. Cancer Letters. 203(1). 51–57. 1 indexed citations
18.
Guo, Jinhu, et al.. (2003). In silico analysis indicates a similar gene expression pattern between human brain and testis. Cytogenetic and Genome Research. 103(1-2). 58–62. 53 indexed citations
19.
Wang, Yanqing, Shin‐ichi Ugai, Osamu Shimozato, et al.. (2003). Induction of systemic immunity by expression of interleukin‐23 in murine colon carcinoma cells. International Journal of Cancer. 105(6). 820–824. 49 indexed citations
20.
Sakiyama, Shigeru, Ling Yu, M. Tomizawa, et al.. (2003). Utilization of the promoter region of the midkine gene as a tool to drive therapeutic genes in a tumor specific manner. Advances in Enzyme Regulation. 43(1). 57–66. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deepak B. Thimiri Govinda Raj Breakdown of academic impact, for papers by Funan Liu Breakdown of academic impact, for papers by Yuge Zhao Breakdown of academic impact, for papers by Sufang Zhou Breakdown of academic impact, for papers by Zhao Yang Breakdown of academic impact, for papers by Fang Xie Breakdown of academic impact, for papers by Wen-Yu Pan Breakdown of academic impact, for papers by Maura Montani
Rankless by CCL
2026